NORMALISIERUNG EINER TUMORMUTATIONSLAST

European patent · EP3704268 · In force

Register entry

Publication number
EP3704268
Application number
EP18872946
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 2, 2018
Published
Sep 9, 2020
Granted
Jan 22, 2025
Protection ends at the latest
Nov 1, 2038
Next annual fee due
Nov 30, 2026
IPC classes
G16B 20/00 (2019.01)
C12Q 1/6827 (2018.01)
C12Q 1/6886 (2018.01)
Priority
US 201762581563 P 03.11.2017
PCT application
PCT/US2018/059068 02.11.2018
PCT publication
WO2019/090156 09.05.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 24, 2025

    Change

    Published in Swissreg on 24.12.2025

  2. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  3. Oct 29, 2025

    Change

    Published in Swissreg on 29.10.2025

  4. Jan 28, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 28.01.2025

  5. Jan 22, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.01.2025

Parties

Holder

Guardant Health, Inc.

3100 Hanover Street, Palo Alto, CA 94304, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

CHUDOVA, Darya

Redwood City, CA 94063, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.